Sagar Vaidya
About Sagar Vaidya
Sagar Vaidya serves as the Vice President of Clinical Development at Travere Therapeutics and has extensive experience in clinical medicine and research. He has held various positions in prestigious institutions, including Massachusetts General Hospital and Harvard Medical School, and has a strong background in infectious diseases and clinical trial management.
Work at Travere Therapeutics
Sagar Vaidya serves as the Vice President of Clinical Development at Travere Therapeutics. He has held this position since 2019, contributing to the company's focus on developing therapies for rare diseases. Vaidya has a track record of delivering robust development plans tailored to each rare disease indication, showcasing his expertise in clinical development and regulatory submissions across various phases of clinical trials.
Education and Expertise
Sagar Vaidya has a strong educational background in the life sciences. He earned a Doctor of Philosophy (PhD) in Microbiology, Immunology, and Molecular Genetics from UCLA in 2003. He also holds a Doctor of Medicine (M.D.) from the David Geffen School of Medicine at UCLA, achieved through the Medical Scientist Training Program (MSTP) in 2006. Additionally, he completed a Bachelor of Science (BS) in Biology at California State University, Los Angeles in 1998. His expertise includes biomarker strategy and pharmacokinetics/pharmacodynamics (PK/PD).
Background in Clinical Medicine
Vaidya has extensive experience in clinical medicine, having worked in various prestigious institutions. He was a Resident Physician at The Mount Sinai Hospital from 2006 to 2010 and completed Infectious Disease Fellowships at Massachusetts General Hospital and Brigham and Women's Hospital from 2010 to 2012. He also served as an Assistant in Medicine at Massachusetts General Hospital's Division of Infectious Diseases and General Medicine from 2012 to 2014.
Previous Roles and Contributions
Prior to his current role at Travere Therapeutics, Sagar Vaidya held significant positions in the biotechnology and academic sectors. He worked as a Senior Medical Director at Sangamo Therapeutics from 2016 to 2019 and as a Medical Director in Clinical Sciences at BioMarin Pharmaceutical Inc. from 2014 to 2016. He also served as an Instructor at Harvard Medical School from 2012 to 2014 and as a Senior Research Fellow at The Ragon Institute of MGH, MIT, and Harvard from 2011 to 2014.
Experience in Research and Development
Sagar Vaidya has a solid foundation in research and development, having worked as a Postdoctoral Research Fellow at the Chinese Academy of Sciences in 2003 and as a Senior Research Fellow at The Ragon Institute from 2011 to 2014. His experience includes managing cross-functional teams in a rapidly-growing matrix environment, which enhances his ability to lead complex clinical development projects.